Cargando…

Climate change and the prevention of cardiovascular disease

Climate change is a worsening global crisis that will continue negatively impacting population health and well-being unless adaptation and mitigation interventions are rapidly implemented. Climate change-related cardiovascular disease is mediated by air pollution, increased ambient temperatures, vec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jacobsen, Alan P., Khiew, Yii Chun, Duffy, Eamon, O'Connell, James, Brown, Evans, Auwaerter, Paul G., Blumenthal, Roger S., Schwartz, Brian S., McEvoy, John William
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	State-of-the-Art Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508346/ https://www.ncbi.nlm.nih.gov/pubmed/36164332 http://dx.doi.org/10.1016/j.ajpc.2022.100391

Ejemplares similares

Opportunities to improve cardiovascular health in the new American workplace
por: Duffy, Eamon Y., et al.
Publicado: (2020)

A Cardio-Oncology Cardiovascular Prevention Framework
por: Marvel, Françoise A., et al.
Publicado: (2019)

Summarizing 2019 in Cardiovascular Prevention using the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease’s ‘ABC’s Approach
por: Feldman, David I., et al.
Publicado: (2020)

The Johns Hopkins Ciccarone Center's expanded ‘ABC's approach to highlight 2020 updates in cardiovascular disease prevention
por: Feldman, David I., et al.
Publicado: (2021)

Medicine 2032: The future of cardiovascular disease prevention with machine learning and digital health technology
por: Javaid, Aamir, et al.
Publicado: (2022)

Depression and cardiovascular comorbidity
por: Glassman, Alexander H.
Publicado: (2007)

Sarcopenia and Cardiovascular Diseases
por: Damluji, Abdulla A., et al.
Publicado: (2023)

Cardiovascular Complications of Down Syndrome: Scoping Review and Expert Consensus
por: Dimopoulos, Konstantinos, et al.
Publicado: (2023)

Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome
por: Hendren, Nicholas S., et al.
Publicado: (2020)

COVID-19, the Pandemic of the Century and Its Impact on Cardiovascular Diseases
por: Zhang, Yuanyuan, et al.
Publicado: (2021)

Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options
por: Jankowski, Joachim, et al.
Publicado: (2021)

Therapeutic and Diagnostic Translation of Extracellular Vesicles in Cardiovascular Diseases: Roadmap to the Clinic
por: Sahoo, Susmita, et al.
Publicado: (2021)

The AHA/ACC/HFSA 2022 Heart Failure Guidelines: Changing the Focus to Heart Failure Prevention
por: Abovich, Arielle, et al.
Publicado: (2023)

No small matter: emerging roles for exosomal miRNAs in the immune system
por: Bauer, Kaylyn M., et al.
Publicado: (2021)

Cardiovascular risk assessment: The foundation of preventive cardiology
por: Wong, Nathan D.
Publicado: (2020)

Aspirin in primary prevention of cardiovascular disease in diabetes
por: Papazafiropoulou, Athanasia K., et al.
Publicado: (2021)

Issues and developments related to assessing function in serious mental illness
por: Brown, Matt A., et al.
Publicado: (2016)

Mild cognitive impairment: historical development and summary of research
por: Golomb, James, et al.
Publicado: (2004)

Modifiable cardiovascular risk factors and genetics for targeted prevention of dementia
por: Juul Rasmussen, Ida, et al.
Publicado: (2023)

(68)Ga-PSMA-11 NDA Approval: A Novel and Successful Academic Partnership
por: Carlucci, Giuseppe, et al.
Publicado: (2021)

The psychobiology of resilience and vulnerability to anxiety disorders: implications for prevention and treatment
por: Charney, Dennis S.
Publicado: (2003)

A systematic approach to venous thromboembolism prevention: a focus on UK experience
por: Clapham, Rachel E., et al.
Publicado: (2022)

Classification of autism and related conditions: progress, challenges, and opportunities
por: Volkmar, Fred R., et al.
Publicado: (2012)

Same evidence, varying viewpoints: Three questions illustrating important differences between United States and European cholesterol guideline recommendations
por: Feldman, David I., et al.
Publicado: (2020)

Interventions for Adherence Improvement in the Primary Prevention of Cardiovascular Diseases: Expert Consensus Statement
por: Ihm, Sang Hyun, et al.
Publicado: (2021)

Drowning risk and climate change: a state-of-the-art review
por: Sindall, Rebecca, et al.
Publicado: (2022)

Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease
por: Halpin, David M. G., et al.
Publicado: (2021)

Identification of female-specific risk enhancers throughout the lifespan of women to improve cardiovascular disease prevention
por: Elder, Petal, et al.
Publicado: (2020)

Cardiac sympathetic denervation in the prevention of genetically mediated life-threatening ventricular arrhythmias
por: Schwartz, Peter J., et al.
Publicado: (2022)

“Threshold‐crossing”: A Useful Way to Establish the Counterfactual in Clinical Trials?
por: Eichler, H‐G, et al.
Publicado: (2016)

Mechanistic and Clinical Overview Cardiovascular Toxicity of BRAF and MEK Inhibitors: JACC: CardioOncology State-of-the-Art Review
por: Glen, Claire, et al.
Publicado: (2022)

Implantable defibrillators in primary prevention of genetic arrhythmias. A shocking choice?( )
por: Corrado, Domenico, et al.
Publicado: (2022)

Implications of the heterogeneity between guideline recommendations for the use of low dose aspirin in primary prevention of cardiovascular disease
por: Li, Xiao-Ying, et al.
Publicado: (2022)

Targeting the Inflammasome in Cardiovascular Disease
por: Olsen, Maria Belland, et al.
Publicado: (2021)

The cardiovascular burden of light smoking
por: Katsi, Vasiliki, et al.
Publicado: (2021)

Iron deficiency and cardiovascular disease
por: Savarese, Gianluigi, et al.
Publicado: (2022)

Immunometabolism at the Heart of Cardiovascular Disease
por: DeBerge, Matthew, et al.
Publicado: (2023)

Polygenic Risk Scores for Atherosclerotic Cardiovascular Disease in the Asia-Pacific Region
por: Tada, Hayato, et al.
Publicado: (2021)

Cardiovascular Precision Medicine in the Genomics Era
por: Dainis, Alexandra M., et al.
Publicado: (2018)

Therapeutic Genome Editing in Cardiovascular Diseases
por: German, David M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_nl99bhv8q852t4c9gcspvna5gm